ReviewEmerging infectious diseases
Controversies about extended-spectrum and AmpC beta-lactamases.
Review in Emerging infectious diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
58 citing papers in PubMed, 228 citations in OpenAlex.
- Genotypic and Phenotypic Detection of AmpC β-lactamases in Enterobacter spp. Isolated from a Teaching Hospital in Malaysia.PloS one · 2016Trial
- Broadly reactive monoclonal antibodies against beta-lactamases for immunodetection of bacterial resistance to antibiotics.Scientific reports · 2025Article
- Multidrug Resistant Escherichia coli among Urinary Samples of Patients with Urinary Tract Infection in the Microbiology Department of a Tertiary Care Center: A Descriptive Cross-Sectional Study.JNMA; journal of the Nepal Medical Association · 2023Article
- Article
- Systematic Review of Plasmid AmpC Type Resistances inMicroorganisms · 2022Article
- In Vitro Activities of Ceftazidime-Avibactam and Aztreonam-Avibactam at Different Inoculum Sizes of Extended-Spectrum β-Lactam-Resistant Enterobacterales Blood Isolates.Antibiotics (Basel, Switzerland) · 2021Article
- CON: Testing for ESBL production is unnecessary for ceftriaxone-resistant Enterobacterales.JAC-antimicrobial resistance · 2021Article
- Evaluation of Two Phenotypic Methods for the Detection of Plasmid-Mediated AmpC β-Lactamases among Enterobacteriaceae Isolates.Journal of laboratory physicians · 2021Article
- Detection of Cephalosporin and Fluoroquinolone Resistance Genes via Novel Multiplex qPCR in FecalFrontiers in microbiology · 2021Article
- Geographical Distribution of β-Lactam Resistance amongTropical medicine and infectious disease · 2019Article
- Rapid Detection of Extended-Spectrum β-Lactamases (ESBL) and AmpC β-Lactamases inFrontiers in microbiology · 2019Article
- Investigating colistin drug resistance: The role of high-throughput sequencing and bioinformatics.F1000Research · 2019Review
- Frequency of Multidrug-Resistant Organisms Cultured From Urine of Children Undergoing Clean Intermittent Catheterization.Journal of the Pediatric Infectious Diseases Society · 2017Article
- Phenotypic and genotypic characteristics of ESBL and AmpC producing organisms associated with bacteraemia in Ho Chi Minh City, Vietnam.Antimicrobial resistance and infection control · 2017Article
- Emergence of co-production of plasmid-mediated AmpC beta-lactamase and ESBL in cefoxitin-resistant uropathogenic Escherichia coli.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2016Article
- Antibiotic Resistance, RAPD- PCR Typing of Multiple Drug Resistant Strains of Escherichia Coli From Urinary Tract Infection (UTI).Journal of clinical and diagnostic research : JCDR · 2016Article
- Bacteremia in Early Infancy: Etiology and Management.Current infectious disease reports · 2016Article
- Community acquired multi-drug resistant clinical isolates of Escherichia coli in a tertiary care center of Nepal.Antimicrobial resistance and infection control · 2015Article
- Detection of ESBL- and AmpC-producing E. coli isolates from urinary tract infections.Advanced biomedical research · 2015Article
- Beta-Lactamase Producing Escherichia coli Isolates in Imported and Locally Produced Chicken Meat from Ghana.PloS one · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Many clinical laboratories have problems detecting extended-spectrum beta-lactamases (ESBLs) and plasmid-mediated AmpC beta-lactamases. Confusion exists about the importance of these resistance mechanisms, optimal test methods, and appropriate reporting conventions. Failure to detect these enzymes has contributed to their uncontrolled spread and sometimes to therapeutic failures. Although National Committee for Clinical Laboratory Standards recommendations exist for detecting ESBL- producing isolates of Escherichia coli and Klebsiella spp., no recommendations exist for detecting ESBLs in other organisms or for detecting plasmid-mediated AmpC beta-lactamases in any organisms. Clinical laboratories need to have adequate funding, equipment, and expertise to provide a rapid and clinically relevant antibiotic testing service in centers where these resistance mechanisms are encountered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.